Basis: FMP quote price / unrounded FMP forward EPS in the trading currency, available after its recorded retrieval time. Source: stored company filings and market data; unavailable inputs remain N/A.
The forward PE ratio is 15.82 as of 2026-09-22T11:55:36.201Z.
Consensus retrieved: 2026-09-13T22:58:53.338Z. This records retrieval, including cache reads, rather than vendor publication. The calculation uses the separately dated price and estimate available at its as-of time.
Calculation as of: 2026-09-22T11:55:36.201Z.
Quote observation: 2026-09-21T20:00:01.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: f4b9e7729f5185b86d1fe31bfa9ad5e5c4bb2067c02838cbdd3f140820241120
Forward PE Ratio (15.82) = Dated Quote Price ($85.20) / Consensus Forward EPS ($5.38)
FORWARD PE RATIO
15.82
SECTOR MEDIAN · HEALTHCARE
18.84
median of 76 covered companies
CURRENT VS SECTOR MEDIAN
-16.05%
vs the sector median at left
Henry Schein, Inc.
Market Cap
$9.71B
Forward PE Ratio
15.82
| NAME | MARKET CAP | FORWARD PE RATIO |
|---|---|---|
| Henry Schein, Inc. (HSIC) | $9.71B | 15.82 |
| Insulet Corp. (PODD)vs › | $9.73B | 21.61 |
| Globus Medical, Inc. (GMED)vs › | $10.02B | 14.86 |
| Bio-Rad Laboratories, Inc. (BIO)vs › | $10.16B | 39.14 |
| The Ensign Group, Inc. (ENSG)vs › | $10.17B | 22.38 |
| Molina Healthcare, Inc. (MOH)vs › | $10.33B | N/A |
| Align Technology, Inc. (ALGN)vs › | $10.52B | 13.01 |
| The Cooper Companies, Inc. (COO)vs › | $10.56B | 11.91 |
| Universal Health Services, Inc. (UHS)vs › | $10.58B | 7.76 |
| Oscar Health, Inc. (OSCR)vs › | $8.11B | 18.15 |
Trailing P/E
24.8
reported TTM EPS
Forward P/E
15.8
consensus EPS · fiscal year ending 2026-12-27
The gap between the two multiples is the consensus growth expectation: analysts' forward EPS of $5.38 implies +56.9% EPS growth vs the reported trailing $3.43.
At the dated quote price of $85.20, each upcoming fiscal year's consensus EPS implies a different multiple — how quickly the price is "paid down" by expected earnings if the estimates hold.
| Fiscal year end | Consensus EPS | Estimate range | Analysts | Implied P/E |
|---|---|---|---|---|
| 2026-12-27 | $5.38 | $5.32 – $5.45 | 11 | 15.8x |
| 2027-12-27 | $6.01 | $5.82 – $6.38 | 11 | 14.2x |
| 2028-12-27 | $6.63 | $5.93 – $7.24 | 6 | 12.8x |
Source: FMP analyst consensus estimates, refreshed with the daily precompute. "n/m" = the consensus EPS is not positive, so a multiple is undefined. There is no forward P/E history chart here because charting one would require the estimates as they stood in the past, which we do not store — see the trailing P/E history for how the realized multiple has moved.
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
